Navigation Links
Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
Date:11/12/2007

http://www.lexpharma.com" target="_new">http://www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking statements," including statements relating to Lexicon's clinical development of LX2931 and the potential therapeutic and commercial potential of LX2931. This press release also contains forward-looking statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information. All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct clinical development of LX2931 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements. Information identifying such important factors is contained under "Factors Affecting Forward-Looking Statements" and "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2006, as filed with the Securities and Exchange Commission. Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
2. Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
3. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
4. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
5. AngioGenex Files Patent on First Small Molecule Id-Inhibitors for the Treatment of Cancer
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
8. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
9. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
10. Replidynes Investigational Antibacterial Agent REP3123 Prevents Sporulation in Clostridium difficile
11. Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... N.Y. , April 21, 2015  Lincoln Computer ... local community and the donations keep coming! LCS donated ... and Dad Alzheimer,s program started by Hebrew Home at ... Good Morning Mom and Dad is a ... help Alzheimer,s residents who are sometimes agitated in the ...
(Date:4/21/2015)... April 21, 2015 ... achieved dazzling export-led growth in just 4 years. ... its part in winning the Queen,s Award for ... to Oxford PharmaGenesis. As part of the world,s ... clients bring new medicines to the world in ...
(Date:4/21/2015)... April 21, 2015  Direct contracting continues to ... aptitude marks its second anniversary.  With over $150M ... single hospital entities, large integrated delivery systems (IDN) ... cover medical surgical items, clinical preference products and ... effective - complementary contracting strategy, aptitude seeks to ...
Breaking Medicine Technology:Lincoln Continues Support of the Community: Donates 10 Laptops for Alzheimer's Program 2Queen's Award Crowns Achievements of Fast-growing London Consultancy 2Queen's Award Crowns Achievements of Fast-growing London Consultancy 3Queen's Award Crowns Achievements of Fast-growing London Consultancy 4Queen's Award Crowns Achievements of Fast-growing London Consultancy 5Healthcare's first direct contracting market celebrates second anniversary 2
... 2011 NxStage® Medical, Inc. (Nasdaq: NXTM ... announced that its Chief Executive Officer, Jeffrey H. Burbank, ... Voice of New England Innovation, 2011 All-Stars Awards. The ... New England,s innovation economy. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO) ...
... Ventana Medical Systems , Inc., (Ventana) a member of the Roche ... efficiency and throughput in today,s anatomic pathology laboratories. The new product ... annual meeting on Sept. 11, 2011, at 12:12 ... The real promise associated with the transition to ...
Cached Medicine Technology:NxStage Medical Founder and CEO Jeffrey Burbank Honored With Mass High Tech All-Star Award 2NxStage Medical Founder and CEO Jeffrey Burbank Honored With Mass High Tech All-Star Award 3NxStage Medical Founder and CEO Jeffrey Burbank Honored With Mass High Tech All-Star Award 4Innovative Digital Pathology Solutions to be Unveiled at CAP '11 2
(Date:4/21/2015)... 2015 QuickMedical, a veteran-owned leader ... now represents Schiller America's line of ... Tests, and Vital Signs Monitors, among many other ... a global leader in the development and production ... in close cooperation with the world's leading physicians ...
(Date:4/21/2015)... Respected academic institution selects Visage 7 ... Visage Imaging Inc. (“Visage”), a wholly owned subsidiary of ... seven-year contract with University of Florida Health — a ... deal furthers the penetration of Visage 7 ... of the North American enterprise imaging market. Visage ...
(Date:4/21/2015)... Baltimore, Maryland (PRWEB) April 21, 2015 ... air, according to the U.S. Environmental Protection Agency (EPA). ... UV rays and cigarette smoke increase the level of ... help the body eliminate these harmful toxins is to ... superfood, broccoli boasts the highest level of glucoraphanin – ...
(Date:4/21/2015)... PA (PRWEB) April 21, 2015 Health ... company and a subsidiary of West Corporation, is hosting ... Health Advocacy solution and the benefits of offering this ... on more responsibility for managing their healthcare, it is ... information necessary to effectively utilize their health benefits. Health ...
(Date:4/21/2015)... April 21, 2015 Le Petit Retreat Day ... its doors today in the leafy, historic Larchmont neighborhood, newly ... and a new theme of “Disconnect to Reconnect.” Tina ... of the award-winning day spa, announces the new name and ... Mother’s Day offerings that help celebrate connections with Moms and ...
Breaking Medicine News(10 mins):Health News:QuickMedical Launches New Product Line: Schiller America 2Health News:QuickMedical Launches New Product Line: Schiller America 3Health News:Visage Imaging Signs University of Florida Health 2Health News:Visage Imaging Signs University of Florida Health 3Health News:Visage Imaging Signs University of Florida Health 4Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 2Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 3Health News:Health Advocate Webinar Discusses Benefits of Health Advocacy 2Health News:Larchmont Sanctuary Spa Revealed as New Name For Neighborhood Spa; New Owner, New Eco Offerings & New Theme: “Disconnect to Reconnect” 2Health News:Larchmont Sanctuary Spa Revealed as New Name For Neighborhood Spa; New Owner, New Eco Offerings & New Theme: “Disconnect to Reconnect” 3
... patients., , , FRIDAY, Jan. 16 (HealthDay News) -- Rheumatoid ... severely than men, new research suggests. , In a ... world who had RA, about 79 percent of them ... in key measures such as symptoms and severity, especially ...
... 16 More than 15,000 students at 53 ... the Presidential Active Lifestyle Award (PALA) program sponsored ... Green Central Park Community School students will host ... Perkins, along with Minneapolis Mayor R.T. Rybak, General ...
... Jan. 16 It,s no secret that the,economic ... and eat. But, are you,willing to sacrifice your ... like other consumers in a recent nationwide study ... nutritious, convenient and,all-natural snacks. There are many healthy ...
... TAMPA, Fla., Jan. 16 The National Autism Association ... of Project Lifesaver funding through the organization,s FOUND Program. ... the rise in wandering-related deaths among children with autism. ... have died as a result of wandering.Project Lifesaver is ...
... /PRNewswire-Asia-FirstCall/ -- Mindray Medical,International Limited (NYSE: ... medical devices worldwide, today announced updates on new ... international markets in,2009. , ... ten products, achieving the goals,for new product development ...
... estate agents make record donation to the Children,s Miracle Network (CMN) ... estate market. RE/MAX is the Chicago real estate/Illinois real estate ... imarily benefit Children,s Memorial Hospital in Chicago. , ... ...
Cached Medicine News:Health News:Rheumatoid Arthritis Hits Women Harder 2Health News:Americans Continue Eating Nutritious and Convenient Snacks Despite Tough Economic Times 2Health News:Americans Continue Eating Nutritious and Convenient Snacks Despite Tough Economic Times 3Health News:Tampa is Latest Recipient of Project Lifesaver Grant Funds Through The National Autism Association 2Health News:Mindray Medical Achieves 2008 Product Development Goals and Announces Strong Pipeline for 2009 2Health News:Mindray Medical Achieves 2008 Product Development Goals and Announces Strong Pipeline for 2009 3Health News:Mindray Medical Achieves 2008 Product Development Goals and Announces Strong Pipeline for 2009 4Health News:Mindray Medical Achieves 2008 Product Development Goals and Announces Strong Pipeline for 2009 5Health News:RE/MAX Northern Illinois Real Estate Agents Raises $284,000 For CMN In 2008, An 18 Percent Increase Over Prior Year 2
... a simple, effective screening test which is used ... sugar) levels which are often a warning sign ... test which requires a single drop of blood ... was shown in clinical trials to be 94 ...
The Lifestream Plus Cholesterol Monitor provides you with a comprehensive tool to help you monitor your cholesterol as part of your wellness program....
CardioChek™ PA Portable Whole Blood Test System...
... Accustrip Strep A(ll) Test is ... for the rapid, qualitative detection ... from throat swabs. The test ... an aid in the diagnosis ...
Medicine Products: